American Society of Hematology

Figure 1.

Figure 1. CIR in patients with low (below median) vs high pre-HCT AUC of ATG capable of binding to CD33+ cells (top) or MNCs (bottom).

CIR in patients with low (below median) vs high pre-HCT AUC of ATG capable of binding to CD33⁺cells (top) or MNCs (bottom).

This Feature Is Available To Subscribers Only

Sign In or Create an Account